SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
IMMU 37.54+1.7%Jul 2 4:00 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
bnutman
EMU2
erickerickson
erippetoe
kdd999
mrc758
Renmanco
sysiphus
Vanderm_98
From: sukit2/8/2019 9:27:02 PM
9 Recommendations  Read Replies (1) of 57073
 
Bunch of grown ass men and women getting butt hurt by words on an internet forum. Everyone needs to grow the hell up. The mindless speculation, vilification and conspiracy theory bullshit is growing old and tired. Until the company or FDA gives us something definitive everything else is useless conjecture. What we know...

IMMU was issued a CRL from the FDA
The CRL related to CMC issues
The therapeutic benefits of 132 are significant and not related to the CRL

The company thought the issues were resolved adequate for approval
The FDA disagreed
The company will reapply
The FDA will reassess

We get it...you think Pehl is a lying piece of shit; the FDA is full of people on the take suppressing good medicine; and Behzad is an incompetent VC moron incapable of running a BOD let alone a real company. These point have all been made multiple times and yet we are no closer to the truth nor does any of this discourse give us any real trading or investment guidance.

This month has almost been as bad as the back slapping, high fiving that went on the week before the PDUFA date.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext